July 30, 2025, 03:45:13 (IST)
First malaria treatment for newborn babies receives approval
The first-ever therapeutic treatment for malaria in newborn babies has received approval, a significant milestone in global public health, the Washington Post says in a report. This development is particularly critical for the World Health Organisation’s Africa region, which bore the vast majority of the 597,000 global malaria deaths recorded in 2023, with children under five representing 76 percent of those fatalities. The new treatment, distinct from the preventative RTS,S vaccine, is viewed by development economists as a strategic investment in Africa’s human capital, with the potential to boost long-term economic growth by reducing infant mortality. However, its success hinges on the implementation capacity of African governments and sustained financing from international partners like the Global Fund, placing pressure on health ministries to ensure effective and equitable distribution.